tweenvest

Guangdong True Health Medical Technology Development Co., Ltd. (SEHK: 2697)

Salud · Equipos y suministros sanitarios · CN

43,42 HK$

-7,62 % hoy · -89,1 % 1 año

Ficha pública
Un resumen gratuito de Guangdong True Health Medical Technology Development Co., Ltd., con datos del 15 nov 2026. El análisis completo está en la app.Abrir en la app

Guangdong True Health Medical Technology Development Co., Ltd. (SEHK: 2697) opera en la industria de equipos y suministros sanitarios dentro del sector salud. Su valor en bolsa es de 197,28 M $ y tiene 158 empleados.

En los últimos doce meses la acción ha bajado un 89,1 % y ha cotizado entre 42,96 y 886,00.

Tweenvest puntúa a Guangdong True Health Medical Technology Development Co., Ltd. en cuatro factores: calidad 46/100, valor 76/100. Su punto más fuerte es valor.

Evolución de la cotización de 2697

3 jul 2026 · 427,60Cierres semanales 43,42 – 810,0016 nov 2026 · 43,42

Cifras clave

Capitalización
197,28 M $
Ingresos (últ. 12 m)
2,60 M $
PER
-15,23
BPA
-3,37
Rent. por dividendo
—
Beta (5 años)
—
Máximo 52 semanas
886,00 HK$
Mínimo 52 semanas
42,96 HK$
Volumen medio (3 m)
—
Acciones en circulación
35,65 M
Empleados
158
Próximos resultados
—

Sobre Guangdong True Health Medical Technology Development Co., Ltd.

Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product, including the TH-P series of compact percutaneous puncture surgical robots which are approved for lung and abdominal puncture, the MW150 microwave ablation device, the TH-X Cryo cryoablation robot, the TH-LS KI300 and TH-LS LU100 ex vivo organ preservation and assessment systems. The company was formerly known as True Health (Guangdong Hengqin) Medical Technology Co., Ltd. and changed its name to Guangdong True Health Medical Technology Development Co., Ltd. in October 2025. The company was incorporated in 2018 and is based in Zhuhai, China.

ISIN
CNE100007QR0
Fundada en
2018
Cotiza desde
30 jun 2026
Bolsa
The Stock Exchange of Hong Kong Ltd.
Divisa
HKD
EmpresaCapitalizaciónPrecioDía
Suzhou Iron Technology CO.,LTDSHSE: 688329201,79 M $18,00 CN¥-2,54 %
AVE Science&Technology CO.,LTDSHSE: 688067200,87 M $19,93 CN¥-2,88 %
ANGEL ROBOTICS Co., Ltd.KOSDAQ: A455900198,52 M $17.240,00 ₩+1,59 %
Pro-Dex, Inc.NasdaqCM: PDEX198,18 M $61,93 $-3,95 %
AOTI, Inc.AIM: AOTI196,90 M $1,40 £+2,19 %
INTAI Technology CorporationTPEX: 4163193,58 M $126,00 NT$0,00 %
Electromed, Inc.NYSEAM: ELMD191,27 M $23,40 $+1,17 %
Nanexa AB (publ)OM: NANEXA189,88 M $9,92 Skr-1,20 %

Ver todas las empresas de equipos y suministros sanitarios →